Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan administration methods in elderly patients with heart failure
ChiCTR-IPR-14005584Phase 4Recruiting
- Sponsor
- Zhejiang Hospital
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of levosimendan in Acute Heart Failure (AHF) (2 arms), sponsored by Zhejiang Hospital. Primary endpoints: Concentration of OR-1896, Hemodynamic parameters and 1 more. Started Oct 2014; status: recruiting.
02
Drugs
levosimendan
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on ChiCTR-IPR-14005584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-14005584.